DGX
Quest Diagnostics IncorporatedNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$21.01B
P/E Ratio
20.61
EPS
$9.21
Beta
0.59
52W High
$212.58
52W Low
$162.47
50-Day MA
$195.19
200-Day MA
$187.52
Dividend Yield
1.75%
Profit Margin
9.08%
Forward P/E
17.45
PEG Ratio
1.44
About Quest Diagnostics Incorporated
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Fundamentals
| Revenue (TTM) | $11.28B |
| Gross Profit (TTM) | $3.75B |
| EBITDA | $2.23B |
| Operating Margin | 14.20% |
| Return on Equity | 14.50% |
| Return on Assets | 6.35% |
| Revenue/Share (TTM) | $101.83 |
| Book Value | $66.36 |
| Price-to-Book | 2.82 |
| Price-to-Sales (TTM) | 1.86 |
| EV/Revenue | 2.372 |
| EV/EBITDA | 12.04 |
| Quarterly Earnings Growth (YoY) | 15.50% |
| Quarterly Revenue Growth (YoY) | 9.20% |
| Shares Outstanding | $110.70M |
| Float | $110.07M |
| % Insiders | 0.42% |
| % Institutions | 97.75% |
Historical Volatility
HV 10-Day
18.82%
HV 20-Day
21.53%
HV 30-Day
25.50%
HV 60-Day
20.91%
HV Rank
71.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($223.25 target)
2
Strong Buy7
Buy9
HoldMore HEALTHCARE Stocks
Data last updated: 5/19/2026